ArticleClinical kidney journal2026

Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.

Murat Özdede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.